Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome
Clinical trial NCT01018953 · TERMINATED
Trial details
- NCT number
- NCT01018953
- Sponsor
- Ipsen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2010-12-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.